Sunday, August 9, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UBS Analyst Upgrades Constellation Energy to Buy with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

According to Wall Street Analyst Ross Fowler at UBS, Constellation Energy (NASDAQ: CEG) continues to receive a Buy rating, with the price target increasing from $151 to $201.

Fowler, known for his expertise in the Utilities sector and a 56.16% success rate covering 28 stocks, is optimistic about Constellation Energy’s future performance in the market.

This updated price target suggests a positive outlook on the company’s potential growth and success as of March 4, 2024.

CEG Stock Shows Strong Performance, Trading Near 52-Week Highs on March 4, 2024

On March 4, 2024, CEG stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates positive price momentum for the stock, suggesting that investors have been bullish on CEG in recent months.

The price of CEG shares saw a significant increase on March 4, with the stock rising by $5.29 since the market last closed. This represents a 3.11% increase in the stock price, signaling strong buying interest in CEG.

The stock opened at $173.09 on March 4, which was $3.09 higher than its previous close. This opening price indicates a positive start to the trading day for CEG, with investors showing confidence in the stock’s potential for growth.

CEG Stock Analysis: Revenue Decline, Net Income Surge, and EPS Fluctuations on March 4, 2024

On March 4, 2024, CEG stock saw some interesting movements in its performance based on the financial data provided by CNN Money. The company reported a total revenue of $21.14 billion for the past year, which represented a 13.51% decrease compared to the previous year. However, the total revenue remained flat at $4.86 billion for the last quarter.

In terms of net income, CEG reported a net income of $1.62 billion for the past year, showing a significant increase of 1114.38% compared to the previous year. However, the net income for the last quarter was -$36.00 million, indicating a decrease of 104.92% compared to the previous quarter.

Earnings per share (EPS) also showed significant changes for CEG stock. The company reported an EPS of $5.01 for the past year, reflecting an impressive increase of 1126.92% compared to the previous year. However, the EPS for the last quarter was -$0.11, showing a decrease of 104.97% compared to the previous quarter.

Overall, the financial performance of CEG stock on March 4, 2024, was a mixed bag with some positive and negative indicators. While the company saw a significant increase in net income and EPS compared to the previous year, there was a decline in net income and EPS for the last quarter. Investors and analysts will closely monitor the company’s future performance to determine its long-term growth potential and stock value.

Tags: CEG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Automotive Stock Market Today

Tesla Stock Plummets in China Ford Dominates US Market A Tale of Two Automakers

DrugRetailers Trading online

Joann Stock Plummets Amid Bankruptcy Consideration and Financial Challenges

Finances and charts

Phunware Stocks Rise Amidst TrumpRelated Market Volatility

Recommended

Biotechnology Stock Bull Market

Analyst Reiterates Buy Rating and 12 Price Target for Shattuck Labs Citing Promising Potential in Biotech Sector

2 years ago
Sangamo Therapeutics Stock

A Regulatory Milestone Sparks Renewed Interest in Sangamo Therapeutics

7 months ago
Diginex Stock

Leadership Shift at Diginex as ESG Software Founder Takes Helm

6 months ago
Novo Nordisk Stock

Novo Nordisk’s Bold Gambit: Price Cuts and Restructuring Amid Market Pressure

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

Amazon’s Three-Trillion-Dollar Moment: A Founder’s Exit, a $220 Billion Wager, and the Fine Print Behind the Record Numbers

The AI Payoff Shifts: Airbnb, SpaceX, and Crypto Show Their Hand

Trending

Novo Nordisk Stock
European Markets

Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline

by SiterGedge
August 8, 2026
0

Novo Nordisk is getting one piece of good news that is easy to count: Wegovy has now...

Nvidia Stock

Nvidia’s Latest Surge Is About More Than a Single Order

August 8, 2026
Plug Power Stock

Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

August 8, 2026
Petrobras Stock

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

August 8, 2026
FALLBACK Stock

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

August 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline
  • Nvidia’s Latest Surge Is About More Than a Single Order
  • Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com